Overview
USNA market data
Price History
USNA price chart · 3M
- O
- 13.46
- H
- 14.04
- L
- 13.46
- C
- 14.04
- Vol
- 8,037.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $13.46
- Previous Close
- $13.66
- Day High
- $14.04
- Day Low
- $13.46
- 52 Week High
- $23.25
- 52 Week Low
- $12.60
- 7 Day Return
- +6.48%
- 30 Day Return
- -39.56%
- 90 Day Return
- -23.51%
- 1 Year Return
- -26.78%
- Daily Notional Volume
- $112.8K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 30.39 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.58 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.69 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 1.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.57 – $32.29 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $269.7M · P/B 0.65 · P/S 0.29.
Company News
Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results. Also, the company cut its FY26 guidance below estimates.Benzinga · Aug 5, 2026, 12:11 PM
Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $1.95-$2.29 to $0.76 vs $2.12 Est; Lowers FY2026 Sales Guidance from $925.000M-$1.000B to $910.000M vs $945.097M EstBenzinga · Aug 4, 2026, 8:56 PM
Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 4, 2026, 8:36 PM
8-K filing — USANA HEALTH SCIENCES INC (USNA)SEC EDGAR · Aug 4, 2026, 8:22 PM
Usana Health Sciences Q2 Adj. EPS $(0.07) Misses $0.43 Estimate, Sales $223.273M Miss $235.003M EstimateBenzinga · Aug 4, 2026, 8:11 PM
USANA Extends Nordiq Canada Partnership Through 2030 Winter GamesBenzinga · Jul 20, 2026, 11:19 AM